LETTER TO THE EDITOR FOR COMMENTS ON RECENT ARTICLES
Importance of human papillomavirus vaccination in prevention of cancers among HIV/AIDS patients
 
More details
Hide details
 
Submission date: 2017-09-30
 
 
Final revision date: 2018-01-20
 
 
Acceptance date: 2018-02-12
 
 
Publication date: 2018-09-25
 
 
HIV & AIDS Review 2018;17(3):227-228
 
TOPICS
REFERENCES (15)
1.
Bosch FX, Broker TR, Forman D, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine 2013; 31: H1-H31.
 
2.
Petrosky E, Bocchini Jr JA, Hariri S, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2015; 64: 300-304.
 
3.
Denny LA, Franceschi S, de Sanjosé S, et al. Human papillomavirus, human immunodeficiency virus and immunosuppression. Vaccine 2012; 30: F168-F174.
 
4.
Reusser NM, Downing C, Guidry J, Tyring SK. HPV Carcinomas in Immunocompromised Patients. J Clin Med 2015; 4: 260-281.
 
5.
De Vuyst H, Lillo F, Broutet N, Smith JS. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active anti­retroviral therapy. Eur J Cancer Prevent 2008; 17: 545-554.
 
6.
Malagón T, Franco EL. Human Papillomavirus Vaccination: Making Sense of the Public Controversy. In: Recurrent Respiratory Papillomatosis. Campisi P (ed.). Springer, 2018; 59-94.
 
7.
Franco EL, de Sanjosé S, Broker TR, et al. Human papillomavirus and cancer prevention: Gaps in knowledge and prospects for research, policy, and advocacy. Vaccine 2012; 30: F175-F182.
 
8.
Silverberg MJ, Lau B, Justice AC, et al. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis 2012; 54: 1026-1034.
 
9.
Palefsky JM, Gillison ML, Strickler HD. HPV vaccines in immunocompromised women and men. Vaccine 2006; 24: S140-S146.
 
10.
Lenz P, Lowy DR, Schiller JT. Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells. Eur J Immunol 2005; 35: 1548-1556.
 
11.
Palefsky JM, Gillison ML, Strickler HD. Chapter 16: HPV vaccines in immunocompromised women and men. Vaccine 2006; 24 (Suppl 3): 140-146.
 
12.
Lin C, Franceschi S, Clifford GM. Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis. Lancet Infect Dis 2018; 18: 198-206.
 
13.
Lowy DR, Schiller JT. Reducing HPV-associated cancer globally. Cancer Prev Res (Phila) 2012; 5: 18-23.
 
14.
Lopez A, Mariette X, Bachelez H, et al. Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis. J Autoimmun 2017; 80: 10-27.
 
15.
Joulaei H, Shooshtarian S, Dianatinasab M. Is UNAIDS 90-90-90 target a Dream or a Reality for Middle East and North Africa Region on Ending the AIDS Epidemic? A Review Study. AIDS Rev 2018; 20: 83-93.
 
eISSN:1732-2707
ISSN:1730-1270
Journals System - logo
Scroll to top